Literature DB >> 12117668

A profibrotic polymorphism (of TGFbeta1) in systemic sclerosis.

J P Pandey1, E C LeRoy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12117668      PMCID： PMC1754199          DOI： 10.1136/ard.61.8.671

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  17 in total

1.  Increased serum levels of antibodies against human cytomegalovirus and prevalence of autoantibodies in systemic sclerosis.

Authors:  M Neidhart; S Kuchen; O Distler; P Brühlmann; B A Michel; R E Gay; S Gay
Journal:  Arthritis Rheum       Date:  1999-02

2.  Extensive linkage disequilibrium in small human populations in Eurasia.

Authors:  Henrik Kaessmann; Sebastian Zöllner; Anna C Gustafsson; Victor Wiebe; Maris Laan; Joakim Lundeberg; Mathias Uhlén; Svante Pääbo
Journal:  Am J Hum Genet       Date:  2002-01-28       Impact factor: 11.025

3.  Meta-analysis of systemic sclerosis and exposure to solvents.

Authors:  B K Aryal; S A Khuder; E A Schaub
Journal:  Am J Ind Med       Date:  2001-09       Impact factor: 2.214

Review 4.  A strategy for determining the pathogenesis of systemic sclerosis. Is transforming growth factor beta the answer?

Authors:  E C Leroy; E A Smith; M B Kahaleh; M Trojanowska; R M Silver
Journal:  Arthritis Rheum       Date:  1989-07

5.  Polymorphisms of the transforming growth factor-beta 1 gene in relation to myocardial infarction and blood pressure. The Etude Cas-Témoin de l'Infarctus du Myocarde (ECTIM) Study.

Authors:  F Cambien; S Ricard; A Troesch; C Mallet; L Générénaz; A Evans; D Arveiler; G Luc; J B Ruidavets; O Poirier
Journal:  Hypertension       Date:  1996-11       Impact factor: 10.190

6.  Immunoglobulin allotype gene polymorphisms in systemic sclerosis: interactive effect of MHC class II and KM genes on anticentromere antibody production.

Authors:  H Kameda; J P Pandey; J Kaburaki; H Inoko; M Kuwana
Journal:  Ann Rheum Dis       Date:  1998-06       Impact factor: 19.103

Review 7.  Human cytomegalovirus and the vasculopathies of autoimmune diseases (especially scleroderma), allograft rejection, and coronary restenosis.

Authors:  J P Pandey; E C LeRoy
Journal:  Arthritis Rheum       Date:  1998-01

8.  Genetic control of the circulating concentration of transforming growth factor type beta1.

Authors:  D J Grainger; K Heathcote; M Chiano; H Snieder; P R Kemp; J C Metcalfe; N D Carter; T D Spector
Journal:  Hum Mol Genet       Date:  1999-01       Impact factor: 6.150

9.  Analysis of transforming growth factor beta1 gene polymorphisms in patients with systemic sclerosis.

Authors:  A Crilly; J Hamilton; C J Clark; A Jardine; R Madhok
Journal:  Ann Rheum Dis       Date:  2002-08       Impact factor: 19.103

10.  Association of microsatellite markers near the fibrillin 1 gene on human chromosome 15q with scleroderma in a Native American population.

Authors:  F K Tan; D N Stivers; M W Foster; R Chakraborty; R F Howard; D M Milewicz; F C Arnett
Journal:  Arthritis Rheum       Date:  1998-10
View more
  2 in total

1.  Association of the interleukin-10 1082G/A, 819C/T and 3575T/A gene polymorphisms with systemic sclerosis: a meta-analysis.

Authors:  Wen-jia Peng; Bing-xiang Wang; Hai-feng Pan; Jin-hui Tao; Jun-qing Zhang; Qian He; Chang-chun Xiao; Jing Wang
Journal:  Mol Biol Rep       Date:  2012-02-04       Impact factor: 2.316

Review 2.  The effect of TGF-β1 polymorphism on systemic sclerosis: a systematic review and pooled analysis of available literature.

Authors:  Ya-nan Wan; Yu-jie Wang; Jun-wei Yan; Xiang-pei Li; Jin-hui Tao; Bing-xiang Wang; Wen-jia Peng; Jing Wang
Journal:  Rheumatol Int       Date:  2013-07-18       Impact factor: 2.631
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.